Display options
Cite
Bishop CV, Liddell H, Ischia J, et al. Holmium Laser Enucleation of the Prostate: Comparison of Immediate Postoperative Outcomes in Patients with and without Antithrombotic Therapy. Curr Urol. 2013;7(1):28-33doi: 10.1159/000343549.
Bishop, C. V., Liddell, H., Ischia, J., Paul, E., Appu, S., Frydenberg, M., & Pham, T. (2013). Holmium Laser Enucleation of the Prostate: Comparison of Immediate Postoperative Outcomes in Patients with and without Antithrombotic Therapy. Current urology, 7(1), 28-33. https://doi.org/10.1159/000343549
Bishop, Conrad V, et al. "Holmium Laser Enucleation of the Prostate: Comparison of Immediate Postoperative Outcomes in Patients with and without Antithrombotic Therapy." Current urology vol. 7,1 (2013): 28-33. doi: https://doi.org/10.1159/000343549
Bishop CV, Liddell H, Ischia J, Paul E, Appu S, Frydenberg M, Pham T. Holmium Laser Enucleation of the Prostate: Comparison of Immediate Postoperative Outcomes in Patients with and without Antithrombotic Therapy. Curr Urol. 2013 Aug;7(1):28-33. doi: 10.1159/000343549. Epub 2013 Jul 28. PMID: 24917753; PMCID: PMC3783280.
Copy Download .nbib Format: NLM
Share it on

Curr Urol. 2013 Aug;7(1):28-33. doi: 10.1159/000343549. Epub 2013 Jul 28.

Holmium Laser Enucleation of the Prostate: Comparison of Immediate Postoperative Outcomes in Patients with and without Antithrombotic Therapy.

Current urology

Conrad V Bishop, Heath Liddell, Joseph Ischia, Eldho Paul, Sree Appu, Mark Frydenberg, Trung Pham

Affiliations

  1. Department of Urology, Southern Health, Monash Medical Centre, Bentleigh, Australia.
  2. School of Public Health and Preventive Medicine, Monash University, Clayton, Australia.
  3. Department of Urology, Southern Health, Monash Medical Centre, Bentleigh, Australia ; Department of Surgery, Faculty of Medicine, Monash University, Clayton, Australia.

PMID: 24917753 PMCID: PMC3783280 DOI: 10.1159/000343549

Abstract

OBJECTIVE: To compare the immediate postoperative outcomes of patients with benign prostatic hyperplasia undergoing Holmium laser enucleation of the prostate (HOLEP) with and without full anticoagulation or antiplatelet therapy at the time of surgery.

MATERIALS AND METHODS: A retrospective review was performed on a series of consecutive patients undergoing HOLEP at our institution by a single surgeon from February 2004 to September 2010. Demographic, surgical, pathological and outcome data were collected. Two cohorts were identified on the basis of antithrombotic therapy at the time of surgery. Patients who continued on aspirin, aspirin/dipyridamole, clopidogrel and warfarin throughout the surgery were included in the antithrombotic cohort. Univariate analysis was performed to determine differences in outcomes between the 2 cohorts.

RESULTS: Total 125 consecutive patients underwent HOLEP with 52 patients on antithrombotic therapy at the time of surgery and 73 patients were not on antithrombotic therapy during surgery. Patients in the antithrombotic group were older (75.1 ±7.5 vs. 71.7 ± 8.3 years; p = 0.02) and had a higher median ASA physical status (3 (3-3) vs. 2 (2-3), p < 0.0001). The mean operating time and median specimen volume were not significantly different between the 2 cohorts. The median length of stay (2 (1-3) vs. 1 (1-2) d, p = 0.014) was longer in the antithrombotic cohort. The transfusion rate (7.7 vs. 0%, p = 0.028) was predictably higher in the antithrombotic cohort. No patients required re-operation for bleeding.

CONCLUSIONS: The use of HOLEP in patients on antithrombotic therapy is safe despite the higher surgical risk profile of that particular patient population and the potential increased risk for significant bleeding.

Keywords: Anticoagulants; Laser treatment; Prostate; Prostatic hyperplasia; Urination disorders

References

  1. Eur Urol. 2010 Sep;58(3):384-97 - PubMed
  2. BJU Int. 2006 Jan;97(1):85-9 - PubMed
  3. World J Urol. 2010 Feb;28(1):53-62 - PubMed
  4. J Urol. 2006 Apr;175(4):1428-32 - PubMed
  5. Urology. 1996 Jan;47(1):48-51 - PubMed
  6. J Urol. 2005 Jan;173(1):158-60 - PubMed
  7. Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1047-54 - PubMed
  8. BJU Int. 2011 Apr;107(7):1030-43 - PubMed
  9. J Urol. 2003 Oct;170(4 Pt 1):1270-4 - PubMed
  10. J Urol. 2004 Sep;172(3):1012-6 - PubMed
  11. J Endourol. 2009 Aug;23(8):1343-6 - PubMed
  12. Br J Urol. 1989 Dec;64(6):623-5 - PubMed
  13. J Urol. 2010 Jun;183(6):2128-36 - PubMed
  14. J Endourol. 2005 Dec;19(10):1196-8 - PubMed
  15. BJU Int. 2009 May;103(9):1162-5 - PubMed
  16. Eur Urol. 2006 Nov;50(5):969-79; discussion 980 - PubMed
  17. BJU Int. 1999 Jun;83(9):984-9 - PubMed
  18. J Urol. 1989 Feb;141(2):243-7 - PubMed
  19. Heart. 2006 Aug;92(8):1064-70 - PubMed
  20. Lancet. 2009 Mar 14;373(9667):911-8 - PubMed
  21. Chest. 2012 Feb;141(2 Suppl):7S-47S - PubMed
  22. J Urol. 2007 Apr;177(4):1395-400; quiz 1591 - PubMed
  23. J Urol. 1999 Oct;162(4):1307-10 - PubMed

Publication Types